Healthtech Startups

Vensica is a clinical-stage medical company developing ViXe, a needle-free treatment for overactive bladder that combines the neurotoxin Xeomin with Vibe, an ultrasound-based drug delivery device that microinjects medication into the bladder wall. The company focuses on urology therapeutics for unmet medical needs.

2 investors

Ventuno is a biotech company developing cancer therapies that leverage the immune system to target and eliminate cancer cells in difficult-to-treat tumors. The company focuses on immunotherapy approaches to advance cancer care.

2 investors

Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.

2 investors

Vergent develops tumor-targeted fluorescent imaging agents designed to enhance surgeons' ability to visualize tumors during minimally invasive and robotic-assisted cancer surgery. The company's lead program, abenacianine for injection, is in Phase 2b clinical evaluation for lung cancer surgery applications.

2 investors

Veri provides personalized metabolic health monitoring and guidance using science-based technology to help individuals understand their body's unique needs and improve their health outcomes. The company serves consumers seeking to address metabolic health issues through daily nutritional and lifestyle insights.

2 investors

Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally. The company's proprietary technology creates biological solutions for conditions such as chronic venous insufficiency, peripheral arterial disease, and heart valve disease.

2 investors

Verinnogen develops data collection technology for pre-clinical cancer research, aiming to improve the accuracy, repeatability, and reliability of research data. The company draws on expertise in cancer biology and medical device development.

2 investors

Veriskin makes a handheld, AI-powered medical device that assesses suspect skin growths by imaging cutaneous blood flow in real time, delivering results in about two minutes. It is aimed at clinical skin cancer screening, supporting early detection while reducing false positives and referrals.

2 investors

VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.

2 investors

Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma. Its products serve dermatology prescribers, payers, and patients, with a lead drug-device combination based on topical cantharidin.

2 investors

Verse Therapy provides a practice management platform that helps independent speech-language pathologists handle administrative work, insurance processing, scheduling, and documentation while connecting them with clients through partnerships and marketing support. The service aims to reduce administrative burden on therapists so they can focus on patient care.

2 investors

Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.

2 investors

Vessi Medical develops a minimally invasive cryo spray system for treating urological conditions in the bladder, offering a non-surgical alternative to traditional procedures performed in hospital settings. The system enables office-based treatment without anesthesia in some cases, reducing complications and healthcare costs compared to conventional surgical approaches.

2 investors

Vetcor is a network of veterinary practices that supports over 900 clinics across the US and Canada through a community-focused collaborative model. The company provides operational support and resources to independent veterinary practices while maintaining their local autonomy and commitment to animal care.

2 investors

Vetic operates a network of pet clinics across India, providing veterinary healthcare services including vaccinations, health checks, surgery, deworming, and grooming for pets. It also runs community programs such as vaccination drives at shelters and free health camps in residential societies for pet parents.

2 investors

VetPronto operates a veterinary service that brings licensed veterinarians to pets' homes and workplaces across multiple U.S. markets. The platform uses technology to manage medical records, client communication, and operational workflows, and offers telemedicine and integrated pharmacy services.

2 investors

Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.

2 investors

VetVerifi provides verified pet vaccination records along with smart tags and API access for pet care. Its services target pet owners and pet care providers such as boarding, housing, and veterinary businesses.

2 investors

Vheda Health offers turnkey, evidence-based chronic care, behavioral health, and maternal health programs delivered virtually to Medicaid, Medicare, and SNP health plans across the US. Its programs aim to increase member engagement, lower costs through reduced ER utilization and admissions, and improve health and quality outcomes.

2 investors

ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma. The technology, used via its FLigHT procedure, is aimed at ophthalmic surgeons treating glaucoma without incisional surgery.

2 investors

VIAN Therapeutics develops a topical eye drop treatment for retinal diseases caused by angiogenesis and vascular permeability, offering a non-invasive alternative to intravitreal injections. The lead candidate targets age-related macular degeneration and diabetic macular edema by inhibiting pro-angiogenic factors and inflammatory cytokines.

2 investors

Vibrant Gastro develops a drug-free medical device using micro-vibrations to treat chronic idiopathic constipation in adults. The company's Vibrant System employs the Synchronized Activation Method to mechanically stimulate the colon and improve natural bowel motility.

2 investors

Vibrato Medical develops wearable therapeutic ultrasound devices for treating peripheral artery disease. The company focuses on bringing medical device technology from development through clinical trials and regulatory approval.

2 investors

VIDA provides AI-powered imaging biomarkers and clinical trial imaging services, using its VIDA Intelligence Platform to collect and analyze imaging data across respiratory, cardiovascular, oncology, and other therapeutic areas. It serves drug developers and clinical trial sponsors in the life sciences industry with quantitative image analysis, expert reading services, and digital biobank capabilities.

2 investors